<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"></head><body style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class="">Hi Jacob,<div class=""><br class=""></div><div class="">I hope all’s well. I received the response below from the relevant person in Oxford University about whether or not results can be used by others for commercial purposes. Essentially, unless the research was funded by someone external who might have additional conditions, everything is left to the discretion of the department where the research was undertaken (in this case, the Mathematical Institute).</div><div class=""><br class=""></div><div class="">They also pointed me to this link: <a href="https://www.ox.ac.uk/students/academic/guidance/intellectual-property" style="color: purple; font-family: Calibri, sans-serif;" class="">https://www.ox.ac.uk/students/academic/guidance/intellectual-property</a></div><div class=""><br class=""></div><div class="">I hope that helps!</div><div class=""><br class=""></div><div class="">Thanks, and best wishes,</div><div class="">Robin</div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><i class="">Does the university own the IP in the results? A couple of things to take into consideration here are if any third parties were involved in the research through funding it or collaborating on it.<br class=""><br class="">If the University owns the IP in the results it will ultimately be a decision for the Department as to whether they are happy to grant free access or if they are interested in forming a more formal relationship (if that is a possibility). So I would suggest that you check with the administrator or equivalent as to Department opinion on this.</i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i></div><div class=""><i class=""><br class=""></i><div class="">
<meta charset="UTF-8" class=""><div dir="auto" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><div dir="auto" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><div>----------------------------------------------------------------------<br class="">Dr Robin Thompson<br class="">Assistant Professor of Mathematical Epidemiology<br class="">Mathematics Institute<br class="">University of Warwick, UK<br class=""><a href="http://www.robin-thompson.co.uk" class="">www.robin-thompson.co.uk</a><br class="">----------------------------------------------------------------------</div></div></div>
</div>
<div><br class=""><blockquote type="cite" class=""><div class="">On 24 Jan 2021, at 18:05, Robin Thompson <<a href="mailto:robin.thompson1988@gmail.com" class="">robin.thompson1988@gmail.com</a>> wrote:</div><br class="Apple-interchange-newline"><div class=""><meta http-equiv="Content-Type" content="text/html; charset=us-ascii" class=""><div style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class="">Hi Jacob,<div class=""><br class=""></div><div class="">Thanks for your email. I have asked the relevant person at Oxford University (the institution I was at when this research was undertaken), and I will let you know when I hear back from them.</div><div class=""><br class=""></div><div class="">Thanks, and best wishes,</div><div class="">Robin</div><div class=""><br class=""><div class="">
<meta charset="UTF-8" class=""><div dir="auto" style="caret-color: rgb(0, 0, 0); letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><div dir="auto" style="caret-color: rgb(0, 0, 0); letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><div class="">----------------------------------------------------------------------<br class="">Dr Robin Thompson<br class="">Assistant Professor of Mathematical Epidemiology<br class="">Mathematics Institute<br class="">University of Warwick, UK<br class=""><a href="http://www.robin-thompson.co.uk/" class="">www.robin-thompson.co.uk</a><br class="">----------------------------------------------------------------------</div></div></div>
</div>
<div class=""><br class=""><blockquote type="cite" class=""><div class="">On 22 Jan 2021, at 20:37, Jacob Barhak <<a href="mailto:jacob.barhak@gmail.com" class="">jacob.barhak@gmail.com</a>> wrote:</div><br class="Apple-interchange-newline"><div class=""><div dir="ltr" class="">Hi Robin, and anyone else who wants to comment, <div class=""><div class=""><br class=""></div><div class="">When integrating your model, you may recall I asked for permissions to use it and mentioned licensing issues.</div><div class=""><br class=""></div><div class="">One of your responses was that you have to check with your institution regarding commercial use while you yourself were ok with me reusing your model and had no restrictions.</div><div class=""><br class=""></div><div class="">I wish to explore the licensing issue in this mailing list to show what are approaches of different institutions and individuals to the problem.</div><div class=""><br class=""></div><div class="">Is it possible for you to check about the policy in your institution? The idea is to show some examples of how institutions approach the issue. For example, do they delegate the decision to researchers? Do they have a policy about who holds the copyright? How do they treat commercial entities?</div><div class=""><br class=""></div><div class="">I know in the US, a faculty member in most cases retains rights for their work, this does not always extend to staff and I am not sure about students. I also know that some academic institutions support tech transfer through patents and other endeavours. </div><div class=""><br class=""></div><div class="">I was trying to discuss licenses here:</div><div class=""><a href="https://forum.comses.net/t/issues-with-regard-to-call-for-transparency-of-covid-19-models/8433" target="_blank" class="">https://forum.comses.net/t/issues-with-regard-to-call-for-transparency-of-covid-19-models/8433</a> </div><div class=""><br class=""></div><div class="">Yet this discussion was not concluded. </div><div class=""><br class=""></div><div class="">One notable approach that Sheriff made me aware of is taken by BioModels:</div><div class=""><a href="http://www.ebi.ac.uk/biomodels/faq" class="">http://www.ebi.ac.uk/biomodels/faq</a><br class=""></div><div class="">They avoid the licensing issues by making all models available under CC0</div><div class=""><br class=""></div><div class="">I am showing here some aspects of the issue and asking for you to check with your institution to explore all aspects of this issue so we can properly report those in the white paper.</div><div class=""><br class=""></div><div class=""> Jacob</div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><br class=""></div></div></div>
</div></blockquote></div><br class=""></div></div></div></blockquote></div><br class=""></div></body></html>